Root Financial Partners’s Telix Pharmaceuticals TLX Stock Holding History

Root Financial Partners’s Portfolio TLX Stock Details TLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66	Buy	+6	New	+$68	﹤0.01%	3698

Other funds holding TLX

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Aubrey Capital Management Edinburgh, United Kingdom $115M AUM 51.42% 1-Year Est. Return

WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Root Financial Partners's TLX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 6 shares worth $66. The stake represents ﹤0.01% of the portfolio and ranks #3698 among its holdings.

10 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

Root Financial Partners held 6 shares of Telix Pharmaceuticals worth $66 as of Q3 2026.
Telix Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
Telix Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3698 holding.
10 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.